These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37291237)

  • 1. B1-cell-produced anti-phosphatidylserine antibodies contribute to lupus nephritis development via TLR-mediated Syk activation.
    Ma K; Du W; Wang S; Xiao F; Li J; Tian J; Xing Y; Kong X; Rui K; Qin R; Zhu X; Wang J; Luo C; Wu H; Zhang Y; Wen C; He L; Liu D; Zou H; Lu Q; Wu L; Lu L
    Cell Mol Immunol; 2023 Aug; 20(8):881-894. PubMed ID: 37291237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR4
    Ma K; Li J; Wang X; Lin X; Du W; Yang X; Mou F; Fang Y; Zhao Y; Hong X; Chan KW; Zhang X; Liu D; Sun L; Lu L
    Ann Rheum Dis; 2018 Oct; 77(10):1498-1506. PubMed ID: 29925508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance of increased B1 cell subset and lupus phenotypes in mice and humans is dependent on BLK expression levels.
    Wu YY; Georg I; Díaz-Barreiro A; Varela N; Lauwerys B; Kumar R; Bagavant H; Castillo-Martín M; El Salem F; Marañón C; Alarcón-Riquelme ME
    J Immunol; 2015 Jun; 194(12):5692-702. PubMed ID: 25972485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study.
    Bourse Chalvon N; Orquevaux P; Giusti D; Gatouillat G; Tabary T; Tonye Libyh M; Chrusciel J; Drame M; Stockton-Bliard G; Amoura Z; Arnaud L; Lorenz HM; Blaison G; Bonnotte B; Magy-Bertrand N; Revuz S; Voll RE; Hinschberger O; Schwarting A; Pham BN; Martin T; Pennaforte JL; Servettaz A
    Front Immunol; 2020; 11():597863. PubMed ID: 33381119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
    Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
    Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid Antibodies in Lupus Nephritis.
    Parodis I; Arnaud L; Gerhardsson J; Zickert A; Sundelin B; Malmström V; Svenungsson E; Gunnarsson I
    PLoS One; 2016; 11(6):e0158076. PubMed ID: 27336701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis.
    Tsai CY; Li KJ; Shen CY; Lu CH; Lee HT; Wu TH; Ng YY; Tsao YP; Hsieh SC; Yu CL
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro assay for detection of glomerular binding IgG autoantibodies in patients with systemic lupus erythematosus.
    Budhai L; Oh K; Davidson A
    J Clin Invest; 1996 Oct; 98(7):1585-93. PubMed ID: 8833907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
    Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
    Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of monoclonal antibodies against human renal glomerular endothelial cells in lupus nephritis that induce endothelial interferon-alpha production.
    Hu YC; Tsai IJ; Hsu HY; Chiang BL; Yang YH
    Arthritis Res Ther; 2021 Jun; 23(1):171. PubMed ID: 34134755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice.
    Xiang L; Liu A; Xu G
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1258-F1270. PubMed ID: 32249615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC; Zhou B; Dong Y
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
    Hardt U; Larsson A; Gunnarsson I; Clancy RM; Petri M; Buyon JP; Silverman GJ; Svenungsson E; Grönwall C
    Arthritis Res Ther; 2018 Feb; 20(1):36. PubMed ID: 29482604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis.
    Pohlmeyer CW; Shang C; Han P; Cui ZH; Jones RM; Clarke AS; Murray BP; Lopez DA; Newstrom DW; Inzunza MD; Matzkies FG; Currie KS; Di Paolo JA
    BMC Rheumatol; 2021 Mar; 5(1):15. PubMed ID: 33781343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phoenix from the flames: Rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis.
    Ramanujam M; Steffgen J; Visvanathan S; Mohan C; Fine JS; Putterman C
    Autoimmun Rev; 2020 Nov; 19(11):102668. PubMed ID: 32942031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis.
    Cheng Q; Mumtaz IM; Khodadadi L; Radbruch A; Hoyer BF; Hiepe F
    Ann Rheum Dis; 2013 Dec; 72(12):2011-7. PubMed ID: 24114925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis.
    Seret G; Cañas F; Pougnet-Di Costanzo L; Hanrotel-Saliou C; Jousse-Joulin S; Le Meur Y; Saraux A; Valeri A; Putterman C; Youinou P; Rojas-Villarraga A; Anaya JM; Renaudineau Y
    J Autoimmun; 2015 Jul; 61():54-61. PubMed ID: 26071203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of anti-nucleosome antibody (ANuA) isotypes for the diagnosis and prediction of systemic lupus erythematosus and lupus nephritis activity.
    Zeng Y; Xiao Y; Zeng F; Jiang L; Yan S; Wang X; Lin Q; Yu L; Lu X; Zhang Y; Lin Y
    Clin Exp Med; 2023 Sep; 23(5):1677-1689. PubMed ID: 36385418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of circulating miR-148a and miR-126 with autoantibodies as biomarkers of lupus nephritis in patients with SLE.
    Omidi F; Khoshmirsafa M; Kianmehr N; Faraji F; Delbandi A; Seif F; Shekarabi M
    J Immunoassay Immunochem; 2022 Nov; 43(6):634-647. PubMed ID: 35938736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.